Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
JNJ-77242113 for moderate to severe plaque psoriasis
ISRCTN69978417Phase 3Active, not recruiting
- Sponsor
- Janssen Pharmaceutical
- Start
- Feb 2024
- Modality
- Peptides
01
Overview
Phase 3 trial of icotrokinra, sponsored by Janssen Pharmaceutical. Started Feb 2024; status: active, not recruiting.
02
Drugs
icotrokinra
Beyond the preview
Go deeper on ISRCTN69978417.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN69978417.